d-alpha tocopherol has been researched along with alpha-synuclein in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonham, CC; Davisson, VJ; Hindupur, J; Liu, F; Nguyen, JL; Rochet, JC; Ruf, KJ; Schieler, JL; Wood, KV; Zhu, J | 1 |
| Elliot, JJ; Hobson, P; Kim, EM; O'Hare, E | 1 |
| Bhattacharyya, A; Chakrabarti, N; Mitra, S | 1 |
| Albarracin, SL; Barreto, GE; Casas, Z; Gonzalez, J; Morales, L; Samudio, I; Stab, BR; Sutachan, JJ | 1 |
| Auinger, P; Cain, KC; Cholerton, B; Ginghina, C; Liu, C; Shi, M; Stewart, T; Zhang, J | 1 |
1 review(s) available for d-alpha tocopherol and alpha-synuclein
| Article | Year |
|---|---|
Cellular and molecular mechanisms of antioxidants in Parkinson's disease.
Topics: alpha-Synuclein; Animals; Antioxidants; Ascorbic Acid; Carrier Proteins; Cell Death; Dopamine; Dopaminergic Neurons; Humans; Inflammation; Nerve Tissue Proteins; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; Polyphenols; Reactive Oxygen Species; Signal Transduction; Substantia Nigra; Ubiquinone; Vitamin A; Vitamin E | 2012 |
1 trial(s) available for d-alpha tocopherol and alpha-synuclein
| Article | Year |
|---|---|
Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort.
Topics: Adult; Aged; Aged, 80 and over; alpha-Synuclein; alpha-Tocopherol; Antiparkinson Agents; Cognition Disorders; Cohort Studies; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Selegiline | 2014 |
3 other study(ies) available for d-alpha tocopherol and alpha-synuclein
| Article | Year |
|---|---|
Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insults.
Topics: Acetylcysteine; alpha-Synuclein; Animals; Antioxidants; Blotting, Western; Cell Death; Cells, Cultured; Cysteine Proteinase Inhibitors; Dopamine; Humans; Leupeptins; Mesencephalon; Methionine Sulfoxide Reductases; Mice; Neurons; Oxidation-Reduction; Oxidoreductases; Parkinson Disease; Rats; Rotenone; Uncoupling Agents; Vitamin E | 2008 |
Effects of intrahippocampal NAC 61-95 injections on memory in the rat and attenuation with vitamin E.
Topics: alpha-Synuclein; Animals; Conditioning, Operant; Hippocampus; Male; Memory; Memory Disorders; Oxidative Stress; Peptide Fragments; Rats; Rats, Sprague-Dawley; Vitamin E | 2009 |
Differential regional expression patterns of α-synuclein, TNF-α, and IL-1β; and variable status of dopaminergic neurotoxicity in mouse brain after Paraquat treatment.
Topics: alpha-Synuclein; alpha-Tocopherol; Animals; Antioxidants; Behavior, Animal; Catalase; DNA-Binding Proteins; Dopaminergic Neurons; Dose-Response Relationship, Drug; Frontal Lobe; Glutathione Transferase; Herbicides; Hippocampus; Humans; Interleukin-1beta; Male; Mice; Nerve Degeneration; Nerve Tissue Proteins; Nuclear Proteins; Paraquat; Random Allocation; Reactive Oxygen Species; Substantia Nigra; Superoxide Dismutase; Survival Rate; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2011 |